Ziarco Pharma Ltd Report issue

For profit Phase 2
Founded: Sandwich United Kingdom (2012)
Status: Acquired by Novartis (2016)

Organization Overview

First Clinical Trial
2015
NCT02424253
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Active Ingredients

Drugs in Phase 2 Trials (2)

pf-03893787 (2 trials)

pf-05212372 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Dermatitis (Phase 2)

Dermatitis, Atopic (Phase 2)

Eczema (Phase 2)

Psoriasis (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 3
  • # of Trial APIs: 2